NO20044562L - Fremgangsmater for behandling av tarmslyng - Google Patents

Fremgangsmater for behandling av tarmslyng

Info

Publication number
NO20044562L
NO20044562L NO20044562A NO20044562A NO20044562L NO 20044562 L NO20044562 L NO 20044562L NO 20044562 A NO20044562 A NO 20044562A NO 20044562 A NO20044562 A NO 20044562A NO 20044562 L NO20044562 L NO 20044562L
Authority
NO
Norway
Prior art keywords
methods
bowel disease
treating bowel
treating
patient
Prior art date
Application number
NO20044562A
Other languages
English (en)
Norwegian (no)
Inventor
Leo E Otterbein
Augustine M K Choi
Anthony J Bauer
Beverley A Moore
Original Assignee
Univ Pittsburg Of The Commonwe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburg Of The Commonwe filed Critical Univ Pittsburg Of The Commonwe
Publication of NO20044562L publication Critical patent/NO20044562L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20044562A 2002-04-15 2004-10-22 Fremgangsmater for behandling av tarmslyng NO20044562L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37265202P 2002-04-15 2002-04-15
PCT/US2003/005428 WO2003088923A2 (en) 2002-04-15 2003-02-21 Methods of treating ileus

Publications (1)

Publication Number Publication Date
NO20044562L true NO20044562L (no) 2004-11-15

Family

ID=29250888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044562A NO20044562L (no) 2002-04-15 2004-10-22 Fremgangsmater for behandling av tarmslyng

Country Status (15)

Country Link
US (1) US7687079B2 (pl)
EP (1) EP1499333B1 (pl)
JP (1) JP4588325B2 (pl)
CN (1) CN100496509C (pl)
AU (1) AU2003216368B2 (pl)
CA (1) CA2481972A1 (pl)
EA (1) EA200401365A1 (pl)
ES (1) ES2546280T3 (pl)
HR (1) HRP20040972A2 (pl)
MX (1) MXPA04010243A (pl)
NO (1) NO20044562L (pl)
PL (1) PL373002A1 (pl)
RS (1) RS91004A (pl)
UA (1) UA85041C2 (pl)
WO (1) WO2003088923A2 (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
BR0210599A (pt) * 2001-06-21 2004-07-20 Beth Israel Hospital Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP2042181A1 (en) * 2002-02-04 2009-04-01 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
CA2481786A1 (en) * 2002-04-15 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating necrotizing enterocolitis
EA200401365A1 (ru) 2002-04-15 2005-04-28 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Способы лечения илеуса
CA2482260A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Inc. Use of heme oxygenase-1 and products of heme degradation
HRP20041071A2 (en) * 2002-05-17 2005-06-30 Yale University University of Pittsburgh of the Commonwealth Syste Methods of treating hepatitis
AU2003248621A1 (en) * 2002-06-05 2003-12-22 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating angiogenesis, tumor growth, and metastasis
RS110504A (sr) * 2002-06-21 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Farmaceutska upotreba azot monoksida, hem oksigenaze-1 i proizvoda raspadanja hema
CN1719975A (zh) * 2002-11-07 2006-01-11 联邦高等教育系统匹兹堡大学 出血性休克的治疗
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
US8893717B2 (en) 2005-09-21 2014-11-25 Ino Therapeutics Llc Systems and methods of administering a pharmaceutical gas to a patient
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
US20070207993A1 (en) * 2005-12-20 2007-09-06 Alfama - Investigacao E Desenvolvimetno De Productos Farmaceuticos Lda Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
HUE035088T2 (en) * 2009-05-27 2018-05-02 Ino Therapeutics Llc Device for engaging an indexed valve and pressurized canister assembly with a collar
CA3130908A1 (en) 2009-06-30 2010-12-30 Mallinckrodt Hospital Products IP Limited Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
CN109925318A (zh) 2011-01-14 2019-06-25 洛杉矶儿童医院 用于治疗包括镰状细胞疾病的疾病的一氧化碳溶液
US9163044B2 (en) 2011-04-19 2015-10-20 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
JP6134710B2 (ja) 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化ルテニウム放出分子およびその使用
WO2013022946A1 (en) 2011-08-09 2013-02-14 Beth Israel Deaconess Medical Center, Inc. Methods of treating dna damage
BR112014022627A8 (pt) 2012-03-15 2018-06-12 Ino Therapeutics Llc Dispositivo de liberação de óxido nítrico e gás compreendendo óxido nítrico
TW201618795A (zh) 2014-04-15 2016-06-01 波泰里斯股份有限公司 用以改良器官功能及延長器官移植物壽命之系統及方法
US20150328073A1 (en) * 2014-05-19 2015-11-19 Joseph Gerard Archer Hyperbaric Social Establishment or Residence
US11771855B2 (en) * 2017-01-10 2023-10-03 Brian Charles Weiner Methods of treating medical conditions with oxygen
CA3047628C (en) * 2017-01-30 2023-05-16 Opco Medical Aps Device for determination of the hemoglobin amount of a patient
JP6618976B2 (ja) * 2017-11-14 2019-12-11 イノ セラピューティクス エルエルシー 指標付弁と襟部を有する加圧容器組立体を係合するため、かつ薬物送達を調整するための装置と流体連通したプランジャ組立体により直線的に作動させるための装置および方法
JP2021525246A (ja) * 2018-05-23 2021-09-24 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 心臓特異的標的化ペプチド（ｃｔｐ）、組成物およびその使用
JP7396597B2 (ja) 2018-06-08 2023-12-12 住友精化株式会社 炎症性消化器官疾患用組成物
KR20250047165A (ko) * 2023-09-27 2025-04-03 아주대학교산학협력단 복부 컴퓨터 단층 촬영 이미지를 이용한 소장 폐쇄를 분류하는 전자장치 및 방법

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053590A (en) 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4264739A (en) 1979-01-05 1981-04-28 Merck & Co., Inc. Sparger for cell culture system
JPS5679957A (en) 1979-12-05 1981-06-30 Sogo Seibutsu Igaku Kenkyusho:Kk Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this
US5240912A (en) 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5084380A (en) 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
US5449665A (en) 1985-09-24 1995-09-12 Item Development Aktiebolag Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
DE3739650C1 (de) 1987-11-23 1989-05-24 Immuno Ag Fermenter zum Zuechten von Zellkulturen
US5180366A (en) 1990-10-10 1993-01-19 Woods W T Apparatus and method for angioplasty and for preventing re-stenosis
US5792325A (en) 1990-11-15 1998-08-11 Richardson, Jr.; William H. Electric arc material processing system
US5293875A (en) 1992-06-16 1994-03-15 Natus Medical Incorporated In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods
US5498421A (en) 1993-02-22 1996-03-12 Vivorx Pharmaceuticals, Inc. Composition useful for in vivo delivery of biologics and methods employing same
WO1994022482A1 (en) * 1993-03-26 1994-10-13 Biorelease Technologies, Inc. Compositions including heme-containing proteins and methods relating thereto
US5763431A (en) * 1993-08-20 1998-06-09 Jackson; Meyer B. Method for regulating neuropeptide hormone secretion
DE4421433C1 (de) 1994-06-18 1995-06-08 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung
US5476764A (en) 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US6066333A (en) 1994-09-22 2000-05-23 William Harvey Research Limited Pharmaceutical control of inflammation
US5664563A (en) 1994-12-09 1997-09-09 Cardiopulmonary Corporation Pneumatic system
US5914316A (en) 1994-12-16 1999-06-22 Washington University Method of inhibiting intimal hyperplasia
US5712293A (en) * 1995-06-07 1998-01-27 Sepracor, Inc. Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride
FR2735382B1 (fr) 1995-06-15 1997-07-25 Air Liquide Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique
ES2217313T3 (es) 1995-06-30 2004-11-01 Zymogenetics, Inc. Bencenosulfonamidas o sulfonilureas de 4-(2-(n-(-2-carboxamidoindol)aminoetilo) como antagonistas del pdfg.
DE69736230T2 (de) * 1996-04-05 2007-05-31 The General Hospital Corp., Boston Behandlung einer hämoglobinstörung
US6069132A (en) 1996-08-14 2000-05-30 Revanker; Ganapathi R. Phosphazole compounds
CN1191836C (zh) 1996-08-27 2005-03-09 梅塞尔集团有限公司 氢气作为药物活性成分在制备药物产品中的用途
WO1998013058A1 (en) 1996-09-27 1998-04-02 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6315995B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US6316403B1 (en) 1996-09-27 2001-11-13 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US8128963B2 (en) 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
ES2243052T3 (es) 1998-03-16 2005-11-16 Celgene Corporation Derivados de la 2- (2,6-dioxopiperidin-3-il) isoindolina, su preparacion y su empleo como inhibidores de las citocinas inflamatorias.
US6203991B1 (en) 1998-08-21 2001-03-20 The Regents Of The University Of Michigan Inhibition of smooth muscle cell migration by heme oxygenase I
US7678390B2 (en) 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
US20050250688A1 (en) 1999-04-01 2005-11-10 The Trustees Of Columbia University In The City Of New York Methods for treating an ischemic disorder and improving stroke outcome
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
FR2812197B1 (fr) 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2816212A1 (fr) 2000-11-03 2002-05-10 Air Liquide Sante Int Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire
IL157580A0 (en) 2001-03-20 2004-03-28 Glaxo Group Ltd Inhalation drug combination
EP1381354A2 (en) 2001-03-30 2004-01-21 Sangstat Medical Corporation Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
EP1395241B9 (en) 2001-05-25 2005-06-15 Medtronic, Inc. Implantable medical device with controllable gaseous agent release system
BR0210599A (pt) 2001-06-21 2004-07-20 Beth Israel Hospital Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
EP2042181A1 (en) 2002-02-04 2009-04-01 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
BRPI0307673A2 (pt) 2002-02-13 2016-11-08 Beth Israel Hospital métodos de tratar doença vascular.
EA200401365A1 (ru) 2002-04-15 2005-04-28 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Способы лечения илеуса
CA2482260A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Inc. Use of heme oxygenase-1 and products of heme degradation
CA2481786A1 (en) 2002-04-15 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating necrotizing enterocolitis
CA2484770A1 (en) 2002-05-09 2003-11-20 Yale University Carbon monoxide as a biomarker and therapeutic agent
HRP20041071A2 (en) 2002-05-17 2005-06-30 Yale University University of Pittsburgh of the Commonwealth Syste Methods of treating hepatitis
AU2003248621A1 (en) 2002-06-05 2003-12-22 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating angiogenesis, tumor growth, and metastasis
RS110504A (sr) 2002-06-21 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Farmaceutska upotreba azot monoksida, hem oksigenaze-1 i proizvoda raspadanja hema
DE10230165A1 (de) 2002-07-04 2004-01-15 Ino Therapeutics Gmbh Verfahren und Vorrichtung zur Administration von Kohlenmonoxid
CN1719975A (zh) 2002-11-07 2006-01-11 联邦高等教育系统匹兹堡大学 出血性休克的治疗

Also Published As

Publication number Publication date
HRP20040972A2 (en) 2005-06-30
EP1499333B1 (en) 2015-06-24
EP1499333A4 (en) 2008-05-28
JP4588325B2 (ja) 2010-12-01
AU2003216368B2 (en) 2007-08-09
CN100496509C (zh) 2009-06-10
WO2003088923A3 (en) 2004-05-06
AU2003216368A1 (en) 2003-11-03
US7687079B2 (en) 2010-03-30
CN1658889A (zh) 2005-08-24
JP2005531534A (ja) 2005-10-20
CA2481972A1 (en) 2003-10-30
RS91004A (sr) 2007-02-05
ES2546280T3 (es) 2015-09-22
EP1499333A2 (en) 2005-01-26
PL373002A1 (pl) 2005-08-08
UA85041C2 (ru) 2008-12-25
US20030219497A1 (en) 2003-11-27
EA200401365A1 (ru) 2005-04-28
MXPA04010243A (es) 2005-07-05
WO2003088923A2 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
NO20044562L (no) Fremgangsmater for behandling av tarmslyng
NO20045056L (no) Fremgangsmater for behandling av hepatitt
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
NO20052348L (no) Behandling av hemoragisk sjokk
NO20045354L (no) Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser
NO20065847L (no) Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
BR0312785A (pt) Tratamento de desordens relacionadas a tnf(alfa)
DK2023918T3 (da) Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
WO2005074598A3 (en) Nitroxyl progenitor compounds and methods of use
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20053111L (no) Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
ATE412636T1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
DE60322395D1 (de) Antipruritisches mittel
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20005223L (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
NO20063319L (no) Anvendelse av siramesin i behandlingen av cancer
NO20065196L (no) Terapeutisk kombinasjon for behandling av Alzheimers sykdom

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application